Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novartis exercises option to inlicense valopicitabine

March 31, 2006

Axcan submits NDA amendment for Helizide

March 30, 2006

Recent patents claim agents for gastrointestinal disorders

March 30, 2006

BioBalance to begin clinic trials of Probactrix for pouchitis

March 30, 2006

Albumin can safely reduce interferon alpha clearance in hepatitis C patients

March 30, 2006

New treatments for hepatitis C described in recent patent literature

March 29, 2006

Chinese data support efficacy of telbivudine in chronic hepatitis B

March 29, 2006

Eisai seeks Japanese approval for Pariet in nonerosive GERD

March 29, 2006

CHMP recommends against approval of Zelnorm for IBS-C in Europe

March 28, 2006

Idenix modifies phase IIb trials of valopicitabine

March 27, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...